Sofosbuvir / Ledipasvir Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Sofosbuvir 400 mg & Ledipasvir 90 mg
Reference Brands: Harvoni®(EU & US)
Category: Anti Viral
Sofosbuvir & Ledipasvir Tablets (400/90 mg) treat Hepatitis C with high cure rates. Available under brands like Harvoni®, Ledifos®, and Hepcinat-LP®, they can be bulk-sourced via PharmaB2B platforms from WHO-GMP-approved manufacturers for tenders, NGOs, and HCV treatment programs worldwide.
Product Description:
Sofosbuvir & Ledipasvir Tablets (400 mg/90 mg) are a powerful, once-daily combination therapy for chronic Hepatitis C. Marketed under global brands like Harvoni®, Ledifos®, and Hepcinat-LP®, this fixed-dose antiviral regimen is recommended by WHO and major liver associations. It offers high cure rates with minimal side effects across genotypes 1, 4, 5, and 6. On PharmaB2B platforms, global buyers can source WHO-GMP and USFDA-approved generic alternatives from trusted Indian manufacturers. Ideal for institutional procurement, NGO supply, and public health programs, Sofosbuvir + Ledipasvir helps scale access to life-saving HCV treatment worldwide.
Sofosbuvir / Ledipasvir — third party manufacturing & bulk supply
Sofosbuvir / Ledipasvir is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Sofosbuvir / Ledipasvir is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Sofosbuvir / Ledipasvir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Sofosbuvir / Ledipasvir →Frequently Asked Questions
Sofosbuvir & Ledipasvir is used for the treatment of chronic hepatitis C virus (HCV) infection, mainly genotype 1, 4, 5, and 6. It helps reduce viral load and supports complete viral clearance with sustained virologic response.
It is made from the active ingredients sofosbuvir, an NS5B polymerase inhibitor, and ledipasvir, an NS5A inhibitor. Together they block HCV replication and viral assembly.
The primary trade name is Harvoni in the USA, EU, and UK, along with multiple licensed generics available in India and other regions.
Harvoni is manufactured by Gilead Sciences. Several licensed generic manufacturers in India and other countries also produce approved generic versions.
The generic name is sofosbuvir & ledipasvir.
The main brand name is Harvoni, with various licensed generic brand names depending on the region.
It is manufactured by Gilead Sciences in the USA and by licensed generic manufacturers in India and other global regions.
Related Products
Ritonavir & Lopinavir
Strength:
Tab: Lopinavir 200 mg + Ritonavir 50 mg; oral solution:80 mg / 20 mg per mL
Form: Tablet and Oral Solution
Reference Brands: Kaletra(US & EU)
View Details
Tenofovir & Emtricitabine
Strength:
Tenofovir DF 300 mg + Emtricitabine 200 mg
Form: Tablet
Reference Brands: Truvada®(US/EU)
View Details
Nelfinavir Mesylate
Strength:
Tablets: 250 mg, 625 mg: Oral Powder: 50 mg/g
Form: Tablet & Oral Powder
Reference Brands: Viracept®
View Details
Atazanavir
Strength:
150 mg, 200 mg, 300 mg
Form: Capsules
Reference Brands: Reyataz®(EU & US)
View Details
Acyclovir
Strength:
500 mg / vial
Form: Lyophilized powder for injection
Reference Brands: Zovirax®(US & EU)
View Details
Acyclovir
Strength:
3%
Form: Eye Ointment
Reference Brands: Zovirax® Eye Ointment(US & Eu)
View Details
Quick Response Guaranteed | Verified Suppliers
